[1]张志敏,刘鑫艳,张永梅,等.急性髓系白血病患者独立生长因子1B表达与各亚型诊断及临床治疗结局的关系[J].陕西医学杂志,2023,52(7):850-854.[doi:DOI:10.3969/j.issn.1000-7377.2023.07.017]
　ZHANG Zhimin,LIU Xinyan,ZHANG Yongmei,et al.Relationship between GFI1B expression in AML patients and diagnosis,clinical treatment outcomes of each subtype[J].,2023,52(7):850-854.[doi:DOI:10.3969/j.issn.1000-7377.2023.07.017]
点击复制

急性髓系白血病患者独立生长因子1B表达与各亚型诊断及临床治疗结局的关系
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
52
期数:
2023年7期
页码:
850-854
栏目:
临床研究
出版日期:
2023-07-05

文章信息/Info

Title:
Relationship between GFI1B expression in AML patients and diagnosis,clinical treatment outcomes of each subtype
作者:
张志敏1; 刘鑫艳2; 张永梅1; 潘志兰1; 林凤茹3; 赵晓君1
(1.石家庄市人民医院血液内科,河北 石家庄 050000; 2.石家庄市中医院内科,河北 石家庄 050011; 3.河北医科大学第二医院血液内科,河北 石家庄 050004)
Author(s):
ZHANG Zhimin; LIU Xinyan; ZHANG Yongmei; PAN Zhilan; LIN Fengru; ZHAO Xiaojun
(Department of Hematology,Shijiazhuang People's Hospital,Shijiazhuang 050000,China)
关键词:
急性髓系白血病;  独立生长因子1B;  慢性粒细胞白血病;  骨髓增生异常综合征;  定量聚合酶链反应
Keywords:
Acute myeloid leukemia;  Independent growth factor 1B;  Chronic myeloid leukemia;  Myelodysplastic syndrome;  Quantitative polymerase chain reaction
分类号:
R 552
DOI:
DOI:10.3969/j.issn.1000-7377.2023.07.017
文献标志码:
A
摘要:
目的:探讨急性髓系白血病(AML)患者独立生长因子1B(GFI1B)的表达与各亚型诊断及临床治疗结局的关系。方法:选取AML患者60例(AML组)、急性淋巴细胞白血病患者(ALL组)26例、慢性粒细胞白血病患者(CML组)18例、骨髓增生异常综合征患者(MDS组)24例,健康志愿者(对照组)10例。采用定量聚合酶链反应(RQ-PCR)法检测各组患者GFI1B基因表达水平; 并将AML患者根据法国(Franch)、美国(American)和英国(Britain)制定的(FAB)分型标准分型,对患者治疗结局进行分层比较。结果:AML组患者的GFI1B mRNA表达水平显著高于ALL组、CML组、MDS组和对照组,差异具有统计学意义(均P<0.05); CML组患者的GFI1B mRNA表达水平高于ALL组、MDS组和对照组,差异具有统计学意义(均P<0.05); ALL组、MDS组患者的GFI1B mRNA表达水平高于对照组,差异具有统计学意义(均P<0.05); M7型AML组患者的GFI1B mRNA表达水平显著高于其他分型的AML患者,差异具有统计学意义(均P<0.05); M6型AML组患者的GFI1B mRNA表达水平显著高于其他分型(M1-M5)的AML患者,差异具有统计学意义(均P<0.05); M4型AML组患者的GFI1B mRNA表达水平显著高于其他分型(M1、M2、M3、M5)的AML患者,差异具有统计学意义(均P<0.05); 60例接受化疗的AML患者中,完全缓解(CR)患者32例、部分缓解(PR)患者16例、未缓解(NR)患者12例; CR+PR组患者治疗前及治疗后的GFI1B mRNA表达水平均显著低于NR组患者,差异具有统计学意义(均P<0.05)。结论: AML患者的GFI1B mRNA表达水平显著高于其他类型白血病患者,其中M7、M6型的GFI1B mRNA表达水平最高; GFI1B mRNA表达水平与AML患者化疗效果有一定的关系。
Abstract:
Objective:To investigate the relationship between the expression of growth factor-independent 1B(GFI1B)in patients with acute myeloid leukemia(AML)and the diagnosis,clinical treatment outcomes of each subtype.Methods:A total of 60 patients with AML(AML group),26 patients with acute lymphoblastic leukemia(ALL group),18 patients with chronic myeloid leukemia(CML group),24 patients with myelodysplastic syndrome(MDS group)and 10 healthy volunteers(control group)were selected.RQ-PCR was used to detect the expression of GFI1B gene in each group.The AML patients were classified according to FAB classification criteria,and the treatment outcomes of the patients were stratified and compared.Results:The mRNA expression level of GFI1B in AML group was significantly higher than that in ALL group,CML group,MDS group and control group(all P<0.05).The expression level of GFI1B mRNA in CML group was higher than that in ALL group,MDS group and control group(all P<0.05).The expression level of GFI1B mRNA in ALL group and MDS group was higher than that in control group(all P<0.05).The expression level of GFI1B mRNA in M7 AML group was significantly higher than that in other types of AML patients(all P<0.05).The mRNA expression level of GFI1B in M6 AML group was significantly higher than that in M1 to M5 AML(all P<0.05).The expression level of GFI1B mRNA in M4 AML group was significantly higher than that in M1,M2,M3,M5 AML(all P<0.05).Among 60 AML patients who received chemotherapy,32 achieved CR,16 achieved PR and 12 achieved NR.The mRNA expression levels of GFI1B in CR+PR group before and after treatment were significantly lower than those in NR group(all P<0.05).Conclusion:The expression level of GFI1B mRNA in AML patients was significantly higher than that in patients with other types of leukemia,among which M7 and M6 types had the highest GFI1B mRNA expression levels.The expression level of GFI1B mRNA had a certain relationship with the chemotherapy effect of AML patients.

参考文献/References:

[1] 张艳君,李建厂,贾秀红,等.FGFR抑制剂BGJ398对白血病细胞生物学行为及耐药的影响[J].中国癌症杂志,2021,31(3):176-181.
[2] 盘婉盈,李可昕,吴惠阳,等.含克拉屈滨的强化预处理方案在异基因造血干细胞移植治疗高危急性髓系白血病患者中的疗效和安全性分析[J].中国实验血液学杂志,2022,30(1):65-71.
[3] Kojima H,Nakayama H,Kosugi N.Bilateral adrenal hemorrhage:A rare presentation of acute myeloid leukemia[J].International Journal of Hematology,2022,115(4):455-456.
[4] Aref S,Rizk R,Agder ME,et al.NOTCH-1 gene mutations influence survival in acute myeloid leukemia patients[J].Asian Pacific Journal of Cancer Prevention,2020,21(7):1987-1992.
[5] Mikhailova EV,Kashpor SA,Zerkalenkova EA,et al.Immunophenotypic characterization of pediatric acute myeloid leukemia with inv(16)(p13.1q22)/t(16; 16)(p13.1; q22)/CBFb-MYH11[J].Pediatric Hematology/Oncology and Immunopathology,2021,20(1):46-53.
[6] Diallo B,Sokhna-Aissatou T,Seck M,et al.Acute panmyelosis with myelofibrosis:A rare subtype of acute myeloid leukemia[J].Open Journal of Blood Diseases,2021,11(3):90.
[7] Al-Khawaja RF,Al-Rubaie HA.The correlation of remission induction therapy with plasma vascular endothelial growth factor level in acute myeloid leukemia patients[J].Postgraduate Medical Journal,2021,20(1):2021.
[8] Brauer D,Backhaus D,Pointner R,et al.Nutritional status at diagnosis and pre-transplant weight loss impact outcomes of acute myeloid leukemia patients following allogeneic stem cell transplantation[J].Hema Sphere,2021,5(3):e532.
[9] Herlin MK,Yones SA,Kjeldsen E,et al.What is abnormal in normal karyotype acute myeloid leukemia in children? analysis of the mutational landscape and prognosis of the TARGET-AML cohort[J].Genes,2021,12(6):792.
[10] Nukui J,Tanaka M,Nakajima H.A case of multiple brain abscesses due toBacillus cereusduring induction therapy for acute myeloid leukemia[J].International Journal of Hematology,2021,114(6):637-638.
[11] 傅 蔷,黄慧芳,原 琴,等.8号四体合并t(9; 11)(p22; q23)的急性髓系白血病一例[J].中华医学遗传学杂志,2020,37(12):1410-1412.
[12] 周柰岑,李国辉,秦炜炜,等.伴ASXL1基因突变的急性髓系白血病患者的临床特征及预后分析[J].中国实验血液学杂志,2021,29(6):1741-1745.
[13] 王 彪,凌 云,戴 莉,等.伴NPM1突变急性髓系白血病二代测序突变基因谱与MICM分型特征关联性分析[J].中国实验血液学杂志, 2022,30(1):56-64.
[14] 王亚萍,吴诗馨,张学亚.急性髓系白血病合并噬血细胞综合征患者的临床分析[J].中国实验血液学杂志,2022,30(1):92-98.
[15] 李剑雄,刘 恒,盛宏霞,等.基于高通量测序技术的急性髓系白血病患者的基因突变谱和预后分析[J].中国实验血液学杂志,2021,29(2):353-362.
[16] 王 晖,李博玲,周 伟,等.参麦注射液对白血病化疗患者不良反应和免疫功能的影响[J].陕西中医,2017,38(10):1441-1442.
[17] 马 兵,张丽红,赵 丹,等.急性髓系白血病患者巨噬细胞移动抑制因子表达水平及其与疗效、预后相关性分析[J].陕西医学杂志,2021,50(12):1558-1561.
[18] 贾闻博,刘金婷,杨新雨,等.伴ASXL1基因突变初诊急性髓系白血病患者的临床特征及生存分析[J].中华血液学杂志,2022,43(10):833-840.
[19] 郝艳梅,纪俊莉,刘纯艺,等.苦参碱联合LY294002对人髓系白血病K562细胞增殖、凋亡和细胞周期的影响[J].南方医科大学学报,2022,42(11):1739-1746.
[20] 刘霄虹,武 莹,黄晓军,等.维奈克拉联合阿扎胞苷治疗NPM1/IDH1突变急性髓系白血病复发患者获持久分子学缓解1例[J].中华血液学杂志,2022,43(2):166.

相似文献/References:

[1]滕 志,雷 秦.去甲氧柔红霉素联合阿糖胞苷对急性髓系白血病患者生存质量及毒副作用的影响[J].陕西医学杂志,2019,(4):521.
　TENG Zhi,LEI Qin..Effects of demethoxydaunorubicin combined with cytarabine on quality of life and side effects in patients with acute myeloid leukemia[J].,2019,(7):521.
[2]崔 雪,崔建娇,丛玉珠,等.四种检验方法不同组合对急性髓系白血病和骨髓增生异常综合征的诊断价值研究[J].陕西医学杂志,2021,50(6):738.[doi:DOI:10.3969/j.issn.1000-7377.2021.06.025]
　CUI Xue,CUI Jianjiao,CONG Yuzhu,et al.Diagnostic value of different combinations of four test methods for AML and MDS[J].,2021,50(7):738.[doi:DOI:10.3969/j.issn.1000-7377.2021.06.025]
[3]王月莉,董 曼.磷脂酰肌醇-3激酶和组蛋白去乙酰化酶双靶点抑制剂CUDC-907对急性髓系白血病细胞体内、体外活性的影响[J].陕西医学杂志,2021,50(8):929.[doi:DOI:10.3969/j.issn.1000-7377.2021.08.007]
　WANG Yueli,DONG Man.Effect of PI3K and HDAC dual target inhibitor CUDC-907 on in-vitro and in-vivo activity of acute myeloid leukemia cells[J].,2021,50(7):929.[doi:DOI:10.3969/j.issn.1000-7377.2021.08.007]
[4]马 兵,张丽红,赵 丹,等.急性髓系白血病患者巨噬细胞移动抑制因子表达水平及其与疗效、预后相关性分析[J].陕西医学杂志,2021,50(12):1558.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.023]
　MA Bing,ZHANG Lihong,ZHAO Dan,et al.Expression level of macrophage migration inhibitory factor in AML patients and its correlation with curative effect and prognosis[J].,2021,50(7):1558.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.023]
[5]宁 可,王海峰,徐 莉,等.急性髓系白血病患者WT1基因表达水平及其在微小残留病灶监测中的临床意义[J].陕西医学杂志,2021,50(12):1577.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.028]
　NING Ke,WANG Haifeng,XU Li,et al.Expression level of WT1 gene in patients with acute myeloid leukemia and its clinical significance in monitoring of minimal residual disease[J].,2021,50(7):1577.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.028]
[6]李 妍,张合成,王国锋,等.外周血中性粒细胞与淋巴细胞比值、淋巴细胞与单核细胞比值对患儿急性髓系白血病疗效及预后的评估价值[J].陕西医学杂志,2022,51(12):1516.[doi:DOI:10.3969/j.issn.1000-7377.2022.12.011]
　LI Yan,ZHANG Hecheng,WANG Guofeng,et al.Value of peripheral blood NLR and LMR in evaluating the efficacy and prognosis of children with acute myeloid leukemia[J].,2022,51(7):1516.[doi:DOI:10.3969/j.issn.1000-7377.2022.12.011]
[7]敖会芳,黄 华,王红权,等.长链非编码RNA RP11-641D5.1通过靶向微小RNA-486-5p调控急性髓系白血病细胞增殖、细胞周期和免疫逃逸实验研究[J].陕西医学杂志,2024,(3):297.[doi:DOI:10.3969/j.issn.1000-7377.2024.03.002]
　AO Huifang,HUANG Hua,WANG Hongquan,et al.Long non-coding RNA RP11-641D5.1 regulates cell proliferation,cell cycle and immune escape in acute myeloid leukemia cells by targeting microRNA-486-5P[J].,2024,(7):297.[doi:DOI:10.3969/j.issn.1000-7377.2024.03.002]
[8]姚 云,廖 冬,周双雄,等.长链非编码RNA CYP1B1-AS1对急性髓系白血病细胞增殖和迁移的影响及机制实验研究[J].陕西医学杂志,2024,(6):723.[doi:DOI:10.3969/j.issn.1000-7377.2024.06.001]
　YAO Yun,LIAO Dong,ZHOU Shuangxiong,et al.Effect and mechanism of long non-coding RNA CYP1B1-AS1on proliferation and migration of acute myeloid leukemia cells[J].,2024,(7):723.[doi:DOI:10.3969/j.issn.1000-7377.2024.06.001]

备注/Memo

备注/Memo:
基金项目:河北省医学科学研究计划项目(20210534,20160803)
更新日期/Last Update: 2023-07-05